Prucalopride NDC 27241-295

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-295Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0295Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-295-30	27241029530	30 TABLET in 1 BOTTLE (27241-295-30)Marketed from Jan 16, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prucalopride
Generic name (nonproprietary): prucalopride
Active ingredients: Prucalopride — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219220
Marketing start: Jan 16, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 4 Receptor Agonists (Mechanism)
Identifiers: Product ID 27241-295_753b960a-a820-4159-b393-96a243bc0150SPL ID 753b960a-a820-4159-b393-96a243bc0150SPL set ID c9d7152d-b117-4346-b60c-dc87b59ead09RxCUI 2107345, 2107353UNII 0A09IUW5TPUPC 0327241295300, 0327241294303
Pharmacologic class: Serotonin-4 Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241029530 followed by a unit qualifier and the quantity

Package 27241-0295-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 24, 2026.

Indications (excerpt from the label)

Prucalopride tablets are indicated for the treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride tablet is a serotonin-4 (5-HT 4 ) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 219220

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 219220
Product	Strength	Form · route	Labeler	Product NDC
Prucalopride	Prucalopride 1 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-294